1 active not recruiting, 1 completed, 1 recruiting. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Active not recruiting 1, Completed 1, Recruiting 1 |
Follow Primary Peritoneal Transitional Cell Carcinoma: new trials by email Literature Review of Primary Peritoneal Transitional Cell Carcinoma trials Research Report on Primary Peritoneal Transitional Cell Carcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Minimally Invasive Surgery After Neoadjuvant Chemotherapy for the Treatment of Stage IIIC-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer, LANCE Trial Chemotherapy, Laparotomy, Minimally Invasive Surgery - Advanced Ovarian Carcinoma, Fallopian Tube Clear Cell Adenocarcinoma | Phase 3 | Recruiting | M.D. Anderson Cancer Center | 580 | 2020-08-05 | 2026-09-14 |
| Bevacizumab and Intravenous or Intraperitoneal Chemotherapy in Treating Patients With Stage II-III Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Bevacizumab, Carboplatin, Cisplatin - Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Adenocarcinoma | Phase 3 | Completed | National Cancer Institute (NCI) | 1560 | 2009-08-11 | 2026-06-02 |
| Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer Bevacizumab, Carboplatin, Docetaxel - Clear Cell Adenocarcinoma, Fallopian Tube Clear Cell Adenocarcinoma | Phase 3 | Active not recruiting | National Cancer Institute (NCI) | 1052 | 2007-12-06 | 2025-12-30 |
Brenner Tumor (2) · Fallopian Tube Neoplasms (2) · Ovarian Neoplasms (2) · Adenocarcinoma, Clear Cell (1) · Adenocarcinoma, Mucinous (1) · Carcinoma (1)
Adnexal Diseases (3) · Endocrine System Diseases (3) · Female Urogenital Diseases (3) · Female Urogenital Diseases and Pregnancy Complications (3) · Genital Diseases (3) · Genital Diseases, Female (3) · Genital Neoplasms, Female (3) · Gonadal Disorders (3) · Neoplasms (3) · Ovarian Diseases (3) · Urogenital Diseases (3) · Urogenital Neoplasms (3) · Endocrine Gland Neoplasms (2) · Fallopian Tube Diseases (2) · Neoplasms by Histologic Type (2)
Bevacizumab (2) · Carboplatin (2) · Disulfides (2) · Immunoglobulin G (2) · Paclitaxel (2) · Taxes (2) · 1,2-diaminocyclohexaneplatinum II citrate (1) · Cisplatin (1) · Docetaxel (1) · Drug Therapy (1) · Gemcitabine (1) · Laparotomy (1) · Minimally Invasive Surgical Procedures (1) · Platinum (1)
National Cancer Institute (NCI) (2) · M.D. Anderson Cancer Center (1)
United States (3) · Canada (1) · Italy (1) · Japan (1) · Mexico (1) · Netherlands (1) · South Korea (1)
Joan L Walker (1) · Jose A Rauh-Hain (1) · Robert L Coleman (1)
PMID 28438473, PMID 31002578, PMID 31722153, PMID 37185961, PMID 39570589
U10CA027469 (2), U10CA180868 (2)